Award
Delivery Order #75N91024F00002
Multi-Year Delivery Order to MRIGlobal for Plasmid DNA Drug Manufacturing
Buyer
National Institutes of Health
Award Amount
$2,790,973.00
Ceiling
$2,790,973.00
Period of Performance
Sep 25, 2024 – Apr 30, 2028
Identifier
75N91024F00002
NAICS
541690
This award is a multi-year delivery order contract granted to MRIGlobal, a biopharmaceutical development company specializing in health research and drug manufacturing. The contract involves the manufacturing of plasmid DNA drug substances and finished drug products, which are crucial for biotechnology treatments including cancer prevention and therapeutic innovation. These materials support clinical and research applications by providing essential pharmaceutical products. The work is conducted at MRIGlobal's facility in Rockville, Maryland, enhancing the agency's capabilities in pharmaceutical production. This competitively procured contract extends a longstanding relationship under a parent Indefinite Delivery Indefinite Quantity (IDIQ) contract focused on chemopreventive agent repository and chemistry support services. The scope includes preparation and delivery of plasmid DNA substances aligned with ongoing therapeutic research needs. The award signifies a strategic investment in advancing biotechnology and public health outcomes through sustained production support. The contract term spans several years with phased milestones designed to support continuous development programs.
Description
MANUFACTURE OF PLASMID DNA DRUG SUBSTANCE AND DRUG PRODUCT